• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.75% Nasdaq Up 0.50%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    17.76 Down 0.36(1.99%) 12:27PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:18.12
    Open:18.22
    Bid:17.66 x 300
    Ask:17.72 x 100
    1y Target Est:24.14
    Beta:1.06642
    Earnings Date:Oct 28 - Nov 2 (Est.)
    Day's Range:17.69 - 18.29
    52wk Range:16.68 - 36.19
    Volume:168,051
    Avg Vol (3m):555,818
    Market Cap:508.30M
    P/E (ttm):N/A
    EPS (ttm):-1.43
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEGR

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 1.99%508.30M
    AZNUp 1.94%81.64B
    PFEUp 0.23%197.63B
    MRKUp 0.23%149.56B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.37
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.99
    Quarterly EPS Est (Sep-15) :-0.42
    Mean Recommendation*:2.9
    PEG Ratio (5 yr expected):-1.70

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback